跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Diquas - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Diquas
Approved
STANDARD
Diquas
Santen Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
ecea6fdcd4735b2e
Company
Santen Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
ecea6fdcd4735b2e
Drug Approval Philippines Name
Diquas
Product Name
Diquas
Registration Number
DR-XY46080
Brand Name
Diquas
Generic Name
Diquafosol sodium
Dosage Form
Ophthalmic Solution
Dosage Strength
30 mg/mL (3% w/v)
Manufacturer
Santen Pharmaceutical Co., Ltd.
Importer
Santen Philippines Inc.
Company Detail Path
/organization/santen-pharmaceutical-co-ltd
Issuance Date
18 December 2024
Expiry Date
06 October 2027
Pharmacologic Category
P2Y2 receptor (purinoceptor) agonist
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
ecea6fdcd4735b2e
Type
Standard
Back to Philippines FDA Approvals